---
title: "GlucoTrack climbs 1% in regular trading on Lokahi Therapeutics deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292779080.md"
description: "GlucoTrack gains 1.4% to $0.54 in regular trading after completing strategic merger with Lokahi Therapeutics."
datetime: "2026-07-15T13:52:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292779080.md)
  - [en](https://longbridge.com/en/news/292779080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292779080.md)
---

# GlucoTrack climbs 1% in regular trading on Lokahi Therapeutics deal

GlucoTrack(GCTK.US) 盘中涨超 1%，现报 0.5365 美元。该股当日涨跌幅为 1.40%，短期波动显著。

消息面上，公司宣布已完成与 Lokahi Therapeutics 的战略业务合并。

### Related Stocks

- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [GlucoTrack enters exchange deal on $900,000 promissory note with investor](https://longbridge.com/en/news/293971923.md)
- [GlucoTrack Restructures Debt Through Equity-Linked Note Exchange](https://longbridge.com/en/news/293975662.md)
- [Glucotrack Merges With Lokahi Therapeutics; Former Holders to Own 90% Post-Conversion](https://longbridge.com/en/news/292819350.md)
- [Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform | GCTK Stock News](https://longbridge.com/en/news/292679068.md)
- [GlucoTrack says USPTO allows patent claims for implantable continuous blood glucose monitoring platform](https://longbridge.com/en/news/292065229.md)